Ledger.Open graph →
SEC Form D · filed July 7, 2015

Clementia Pharmaceuticals Inc

Offering
$60.0M
Sold
$60.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
DORVAL, Quebec, Canada
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Jean-Francois P. Pariseau · Dorval, Quebec, CanadaExec · DirectorDavid P. Bonita · Dorval, Quebec, CanadaDirectorRobert P. Heft · Dorval, Quebec, CanadaDirectorClarissa Desjardins · Dorval, Quebec, CanadaExec · DirectorFrancois P. Nader · Dorval, Quebec, CanadaDirectorDonna R. Grogan · Dorval, Quebec, CanadaExecMichael R. Singer · Dorval, Quebec, CanadaExecEric P. Grinstead · Dorval, Quebec, CanadaExecJeffrey R. Packman · Dorval, Quebec, CanadaExecAllan P. Mandelzys · Dorval, Quebec, CanadaDirectorFrancois P. Nader · Dorval, Quebec, CanadaDirectorDonna R. Grogan · Dorval, Quebec, CanadaExecJean-Francois P. Pariseau · Dorval, Quebec, CanadaExec · DirectorMichael R. Singer · Dorval, Quebec, CanadaExecDavid P. Bonita · Dorval, Quebec, CanadaDirectorRobert P. Heft · Dorval, Quebec, CanadaDirectorClarissa Desjardins · Dorval, Quebec, CanadaExec · DirectorEric P. Grinstead · Dorval, Quebec, CanadaExecJeffrey R. Packman · Dorval, Quebec, CanadaExecAllan P. Mandelzys · Dorval, Quebec, CanadaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗